GPT-Rosalind (OpenAI) vs Microsoft Agent 365

Microsoft Agent 365 edges out GPT-Rosalind (OpenAI) by 0.7 points (7.5 vs 6.8) -- a B-tier vs C-tier split that's narrow but real. Not a blowout; both belong on a shortlist. The score gap shows up most clearly in the categories that matter for Microsoft Agent 365's strengths, so if those categories are your priority, the lead translates.

Neither tool offers a free tier. GPT-Rosalind (OpenAI) starts at Invite only, Microsoft Agent 365 at $15. Plan to budget for whichever you pick. The cheap tier usually caps out faster than buyers expect, so look at what the entry plan actually includes -- both vendors have raised list prices in 2026 and the limits are where most of the cost surprise lives.

By use case: pick GPT-Rosalind (OpenAI) when researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access. Pick Microsoft Agent 365 when enterprise it and security teams running mixed-ai environments who need a single pane of glass over local agents (openclaw, copilot cli, claude code), copilot studio agents, and cloud agents in aws bedrock / google cloud / azure. The two tools aren't fighting for the same person -- they're aiming at adjacent jobs that occasionally overlap. If you're squarely in Microsoft Agent 365's lane, the tier-list ranking and the use-case fit point the same direction; if you're in GPT-Rosalind (OpenAI)'s lane, the score gap matters less than the fit.

Bottom line: Microsoft Agent 365 is the safer default for most readers, but GPT-Rosalind (OpenAI) is competitive enough that the tie-breaker is your specific workload, not the spec sheet.